Panagora Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-21,270
| Closed | -$415K | – | 1501 |
|
|
2022
Q4 | $415K | Sell |
21,270
-53,762
| -72% | -$1.05M | ﹤0.01% | 1209 |
|
|
2022
Q3 | $1.58M | Buy |
75,032
+551
| +0.7% | +$11.6K | 0.01% | 683 |
|
|
2022
Q2 | $1.45M | Buy |
74,481
+4,995
| +7% | +$97.2K | 0.01% | 737 |
|
|
2022
Q1 | $1.53M | Buy |
69,486
+2,427
| +4% | +$53.4K | 0.01% | 763 |
|
|
2021
Q4 | $1.07M | Buy |
67,059
+39
| +0.1% | +$622 | 0.01% | 888 |
|
|
2021
Q3 | $1.34M | Buy |
67,020
+9,268
| +16% | +$185K | 0.01% | 840 |
|
|
2021
Q2 | $999K | Sell |
57,752
-141
| -0.2% | -$2.44K | 0.01% | 987 |
|
|
2021
Q1 | $1.15M | Buy |
57,893
+36,724
| +173% | +$728K | 0.01% | 960 |
|
|
2020
Q4 | $370K | Buy |
+21,169
| New | +$370K | ﹤0.01% | 1347 |
|